Biodesix Inc Cash Flow-to-Debt Ratio
Biodesix Inc cash flow-to-debt ratio. Biodesix Inc (BDSX) has a Cash Flow-to-Debt Ratio of -0.02x as of June 2026, meaning its operating cash flow of $-1.56 Million could theoretically repay 0% of its total liabilities ($86.18 Million) in one year. Check BDSX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Biodesix Inc (2018–2025)
Cash flow-to-debt ratio of Biodesix Inc from 2018 to 2025. Historical debt coverage capacity for Biodesix Inc across 8 annual periods. See debt-free asset ratio of Biodesix Inc to measure how much of total assets are equity-financed.
Biodesix Inc Cash Flow-to-Debt Ratio by Year (2018–2025)
Biodesix Inc cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for Biodesix Inc. For the full cash flow conversion analysis, see Biodesix Inc (BDSX) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.26x | $-23.27 Million | $89.94 Million | ▲ +59.4% |
| 2024 | -0.64x | $-48.65 Million | $76.37 Million | ▼ -163.3% |
| 2023 | -0.24x | $-22.87 Million | $94.52 Million | ▲ +61.1% |
| 2022 | -0.62x | $-44.97 Million | $72.30 Million | ▼ -24.2% |
| 2021 | -0.50x | $-28.22 Million | $56.37 Million | ▼ -87.2% |
| 2020 | -0.27x | $-21.37 Million | $79.90 Million | ▼ -232.5% |
| 2019 | -0.08x | $-21.73 Million | $270.17 Million | ▼ -7.9% |
| 2018 | -0.07x | $-17.68 Million | $237.09 Million | — |